Work

Discovery and Development of Deucravacitinib (BMS-986165), a Small Molecule TYK2 Inhibitor for the Treatment of Autoimmune Diseases

Year: 2025

Type: conference-paper

Source: ACS symposium series

DOI: 10.1021/bk-2025-1505.ch004

Authors: Stephen T. Wrobleski, Daniel S. Treitler, Eric M. Simmons

Institution: Bristol-Myers Squibb (United States)

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Computational Theory and Mathematics

Field: Computer Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410236875

FWCI:

Cites: 1

Cited by:

Related to: 10